GENSCRIPT BIO
Biotechnology · Healthcare
CEO
1 appearance
Latest appearance 2026-08-17
Alan Gork
CEO
GENSCRIPT BIO
Equibles does not estimate personal net worth.
About Alan Gork
Alan Gork is recorded as CEO at GENSCRIPT BIO. Alan Gork has spoken on 1 earnings call across 1 company, most recently for GENSCRIPT BIO on August 17, 2026. GENSCRIPT BIO is classified in the Biotechnology industry within the Healthcare sector.
Alan Gork on recent calls
“So for the first half of 2006, ProBio totally signed $9.7 million US dollar AIDD-related orders, including both for discovery and also CMC project, and actually delivered around $2.5 million revenue.”
Affiliation history
-
GENSCRIPT BIO
CEO
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
2026 Interim Results Conference
GENSCRIPT BIO